Cart
sales@molnova.com
Tegadifur
CAS No. 62987-05-7
Tegadifur( —— )
Catalog No. M33142 CAS No. 62987-05-7
Tegadifur (40497S) is an orally available antitumor compound with antimetabolic effects, often used with uracil and in the treatment of rectal adenocarcinoma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 246 | In Stock |
|
| 5MG | 411 | In Stock |
|
| 10MG | 562 | In Stock |
|
| 25MG | 866 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTegadifur
-
NoteResearch use only, not for human use.
-
Brief DescriptionTegadifur (40497S) is an orally available antitumor compound with antimetabolic effects, often used with uracil and in the treatment of rectal adenocarcinoma.
-
DescriptionTegadifur is a fluorine-containing and anti-metabolic agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number62987-05-7
-
Formula Weight270.26
-
Molecular FormulaC12H15FN2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C(F)=CN(C(=O)N1C2OCCC2)C3OCCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhiquan Zhao, et al. Applications Of Arctigenin In Formulating Drugs For Preventing Or Treating Diseases Related To Red Blood Cell Reduction. US 20130190394 A1
molnova catalog
related products
-
pp60 c-src (521-533)...
Peptide corresponding to the pp60c-src carboxy terminal regulatory domain; phosphorylated at Tyr527. Binds to pp60c-src and pp60v-src at the SH2 domain, suppressing their tyrosine kinase activity and transforming potential.
-
Acyl Carrier Protein...
Acyl Carrier Protein (ACP) (65-74) is an active acyl carrier protein (ACP) fragment.Acyl Carrier Protein (ACP) is a component of plastid-located plant fatty acid synthetase. It binds acyl groups covalently via the prosthetic group, 4-phosphopantetheine, during the biosynthesis of fatty acids.
-
m-PEG9-CH2COOH
m-PEG9-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
